Regnault, Antoine
Bunod, Laurine
Loubert, Angely
Brose, Marcia S.
Hess, Lisa M.
Maeda, Patricia
Lin, Yan
Speck, Rebecca M.
Gilligan, Adrienne M.
Payakachat, Nalin https://orcid.org/0000-0002-9526-5356
Funding for this research was provided by:
Eli Lilly and Company (Eli Lilly and Company)
Article History
Received: 9 August 2024
Accepted: 5 December 2024
First Online: 19 December 2024
Declarations
:
: This study was conducted in accordance with consensus ethical principles derived from international guidelines including the Declaration of Helsinki and Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines.
: All authors read and approved the final manuscript.
: AMG, LMH, NP, PM, RS, and YL are employed by Eli Lilly and Company. AR, AL, and LB are employees of Modus Outcomes, which received payment from Eli Lilly and Company to conduct this research. MSB reports consultancy role for Aadi Bioscience, Bayer, Blueprint, Eisai, Eli Lilly and Company, Exelixis, Ipsen.